As the telehealth adoption landscape evolves through and beyond the COVID pandemic, the industry is watching to see how transformative the technology will truly be. As reimbursement definitions are established and expanded, digital divide challenges are addressed, and technologies are refined, what will this mean for clinical practice? Telehealth has the potential to be relegated to the "as needed" category of technical tools or it can be leveraged to develop new, hybrid practice models--where building and sustaining a meaningful connection between patients and their care teams can impact preventative care and address chronic disease management. According to a recent survey of HIMSS C-suite leaders and decision-makers, 80% of clinicians believe telehealth can be a driver of better patient outcomes if the technology is easy to use and intuitive. Krish Ramakrishnan, Chief Innovator and Strategist for BlueJeans by Verizon, will share Verizon's vision for deploying intelligent, streamlined telehealth and how the company is addressing digital divide so that the most high-risk, low-access patient populations can benefit from virtual care offerings.